ZirMed acquires TransEngen's payment processing and patient engagement solutions

NewsGuard 100/100 Score

ZirMed®, a leading health information connectivity and management solutions company, today announced that it has acquired the payment processing, patient eligibility and patient estimation business solutions owned by TransEngen Inc., a company located in Shelton, CT.

The TransEngen solutions bring to ZirMed deep integration with practice management systems, expanded HIPAA- and PCI-compliant patient online bill pay capabilities, and a unique patient responsibility calculator. The acquired solutions also bring with them a large client base, including several enterprise clients.

"The acquisition of these solutions complements and expands upon our comprehensive revenue cycle management platform, beginning at pre-visit with mobile patient engagement, and ending with reconciliation of patient and payer payment," said Tom Butts, Chairman and Chief Executive Officer, ZirMed. "Healthcare is changing rapidly, with increasing patient financial responsibility and changing payment models, driving the need for more flexible software solutions to manage revenue cycle performance. The acquisition of these TransEngen solutions immediately strengthens our ability to deliver a more robust solution to our clients, and will support our – and our clients' – continued growth."

ZirMed has extensive expertise in financial processing, patient engagement and revenue cycle management and optimization, and the addition of these solutions to the ZirMed technology platform will enhance functionality needed to help clients improve their financial performance. Plans are underway to integrate the TransEngen services into the ZirMed platform, including ZirMed Patient Estimation, Eligibility, and ZPay. The addition of TransEngen's merchant processing and patient engagement client base will expand ZirMed's market share and result in ZirMed processing over $2 billion patient payments annually.

SOURCE ZirMed

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Personalized screening approach may better predict preeclampsia in the first trimester of pregnancy